Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Neuralstem, Inc. (NASDAQ: CUR).

Full DD Report for CUR

You must become a subscriber to view this report.


Recent News from (NASDAQ: CUR)

Neuralstem up 31% premarket on preclinical Alzheimer's data
Thinly traded nano cap Neuralstem (NYSEMKT: CUR ) is up  31%  premarket on light volume following the publication of a manuscript showing the potential of its stem cells to treat Alzheimer's disease (AD). More news on: Neuralstem, Inc., Healthcare stocks news, Stocks on the move,...
Source: SeekingAlpha
Date: October, 25 2018 08:42
Neuralstem Announces Publication of a Study Showing Benefits of Neural Stem Cell (NSC) Transplantation in a Mouse Model of Alzheimer's Disease
NSC transplantation led to improved cognition and reduced Aβ plaque pathology GERMANTOWN, Md., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, announced the publicati...
Source: GlobeNewswire
Date: October, 25 2018 07:00
Neuralstem Provides Business Update and Reports Second Quarter 2018 Fiscal Results
- Phase 2 clinical trial initiated to further evaluate NSI-566 as treatment for ischemic stroke - - NSI-189 Granted Orphan Drug Designation for the Treatment of Angelman Syndrome - - Jim Scully appointed interim chief executive officer - GERMANTOWN, Md., Aug. 15, 2018 (GLOBE NEWSWIR...
Source: GlobeNewswire
Date: August, 15 2018 10:24
Premarket Gainers as of 9:05 am (08/09/2018)
KBSF +62% . More news on: KBS Fashion Group Limited, Belmond Ltd., Dun & Bradstreet Corp., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 09 2018 09:23
Neuralstem Announces NSI-189 Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Angelman Syndrome
GERMANTOWN, Md., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced that the U.S. Food and Drug Administration has granted orphan d...
Source: GlobeNewswire
Date: August, 09 2018 07:00
Neuralstem Appoints Jim Scully as Interim Chief Executive Officer
GERMANTOWN, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, today announced that the Board of Directors has appoin...
Source: GlobeNewswire
Date: August, 06 2018 07:00
CORRECTING and REPLACING -- Neuralstem, Inc.
GERMANTOWN, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, "Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke," rather than, "Neuralstem Announces Initiatio...
Source: GlobeNewswire
Date: August, 01 2018 09:05
Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke
GERMANTOWN, Md., July 31, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced the initiation of a Phase 2 clinical trial evaluating NSI-566, the C...
Source: GlobeNewswire
Date: July, 31 2018 18:14
Biogen slump pressures other biotechs
Biogen's ( BIIB -8.9% ) post-BAN2401 data-stoked drop appears to be affecting some of the other Alzheimer's players. More news on: Biogen Inc., SPDR Biotech ETF, Eisai Co., Ltd. ADR, Healthcare stocks news, Stocks on the move, News on ETFs, Read more ...
Source: SeekingAlpha
Date: July, 26 2018 10:32
Premarket Losers as of 9:05 am (7/24/2018)
BBGI -16% . More news on: Beasley Broadcast Group, Inc., Whirlpool Corporation, Turkcell Iletisim Hizmetleri A.S., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: July, 24 2018 09:08

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.44730.4350.44730.426559,781
2018-12-130.43980.43310.450.4379,344
2018-12-120.4260.42810.45280.4008107,990
2018-12-110.40010.43990.440.400181,556
2018-12-100.4450.43010.4450.39174,972

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1460013,4854.4494Cover
2018-12-132,51413,48118.6485Cover
2018-12-125,49235,03315.6766Cover
2018-12-1130,91240,58876.1604Short
2018-12-101,42130,6164.6414Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CUR.


About Neuralstem, Inc. (NASDAQ: CUR)

Logo for Neuralstem, Inc. (NASDAQ: CUR)

Not available

 

Contact Information

 

 

Current Management

  • Richard Garr / CEO, President

Current Share Structure

  • Market Cap: $25,620,424 - 05/15/2018
  • Issue and Outstanding: 15,160,014 - 02/28/2018

 


Recent Filings from (NASDAQ: CUR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 25 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 24 2018

 

 


Daily Technical Chart for (NASDAQ: CUR)

Daily Technical Chart for (NASDAQ: CUR)


Stay tuned for daily updates and more on (NASDAQ: CUR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CUR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CUR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CUR and does not buy, sell, or trade any shares of CUR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/